Moreover, analysis of public data on the expression levels of c-FLIP (CFLAR), CD95 (FAS/TNFRSF6), and CD95L (FASLG) revealed significantly higher expression of these three genes in ccRCC compared with other renal cancers. The gene discussed is FAS; the disease is nonpapillary renal cell carcinoma.